Abstract:Ensuring the safety and efficacy of chemical compounds is crucial in small-molecule drug development. In the later stages of drug development, toxic compounds pose a significant challenge, losing valuable resources and time. Early and accurate prediction of compound toxicity using deep learning models offers a promising solution to mitigate these risks during drug discovery. In this study, we present the development of several deep-learning models aimed at evaluating different types of compound toxicity, including acute toxicity, carcinogenicity, hERG_cardiotoxicity (the human ether-a-go-go related gene caused cardiotoxicity), hepatotoxicity, and mutagenicity. To address the inherent variations in data size, label type, and distribution across different types of toxicity, we employed diverse training strategies. Our first approach involved utilizing a graph convolutional network (GCN) regression model to predict acute toxicity, which achieved notable performance with Pearson R 0.76, 0.74, and 0.65 for intraperitoneal, intravenous, and oral administration routes, respectively. Furthermore, we trained multiple GCN binary classification models, each tailored to a specific type of toxicity. These models exhibited high area under the curve (AUC) scores, with an impressive AUC of 0.69, 0.77, 0.88, and 0.79 for predicting carcinogenicity, hERG_cardiotoxicity, mutagenicity, and hepatotoxicity, respectively. Additionally, we have used the approved drug dataset to determine the appropriate threshold value for the prediction score in model usage. We integrated these models into a virtual screening pipeline to assess their effectiveness in identifying potential low-toxicity drug candidates. Our findings indicate that this deep learning approach has the potential to significantly reduce the cost and risk associated with drug development by expediting the selection of compounds with low toxicity profiles. Therefore, the models developed in this study hold promise as critical tools for early drug candidate screening and selection.

Machine Learning Models for Predicting Liver Toxicity

Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals

Machine Learning for Predicting Organ Toxicity

Applications of Machine Learning Methods in Drug Toxicity Prediction.

Review of machine learning and deep learning models for toxicity prediction

A Prediction Model for COVID-19 Liver Dysfunction in Patients with Normal Hepatic Biochemical Parameters

Drug Toxicity Prediction by Machine Learning Approaches

Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development

Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point

Drugs Toxicity Prediction: A Review

Prediction of clinically relevant drug‐induced liver injury from structure using machine learning

In silico prediction of potential drug-induced nephrotoxicity with machine learning methods

AOP-Based Machine Learning for Toxicity Prediction

Machine Learning Models for Predicting Cytotoxicity of Nanomaterials.

A Deep Learning Based Multi-Model Approach for Predicting Drug-Like Chemical Compound’s Toxicity

Development of novel tools for the in vitro investigation of drug-induced liver injury

In silico models for the prediction of dose-dependent human hepatotoxicity

In Silico Prediction Of Chemical Toxicity For Drug Design Using Machine Learning Methods And Structural Alerts

Advances In Machine Learning Prediction Of Toxicological Properties And Adverse Drug Reactions Of Pharmaceutical Agents

Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints

Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events